Categories: Research

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...

Sheng Ding, PhD, is a stem cell scientist who uses novel small molecules to control and reprogram stem cell activities in various tissue types. Applying his groundbreaking techniques, he has previously succeeded in transforming skin cells into functional brain, heart, liver, and insulin-producing...

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies. The RAN is a consortium comprising researchers from the UCSF School of Pharmacy (UCSF Antibiome Center), the University of Chicago,...

UCSF School of Pharmacy faculty member Shuvo Roy, PhD, has received a three-year $1 million grant to create surgically implantable capsules of donor pancreas cells to free type 1 diabetes patients from daily insulin injections and the disease’s potentially life-threatening complications. The work...

Altschuler

GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors.
Thorne CA, Wichaidit C, Coster AD, Posner BA, Wu LF, Altschuler SJ. Nat Chem Biol.

A simple image correction method for high-throughput microscopy.
Coster AD, Wichaidit C, Rajaram S, Altschuler...

How does brain circuitry organize itself during development? In at least one case—the seemingly complex visual system of the fruit fly, which connects its 800-facet compound eyes to its brain—the answer lies in just three simple rules.